Father of Seven Begs Wellpoint for Gene Test

June 29 (Bloomberg) -- Matt Christman, a civil engineer in Huntington, Indiana, has hypertrophic cardiomyopathy, an inherited condition that kills 1,600 people in the U.S. annually. Each of his seven children has a 50 percent chance they'll have the same disorder. Anthem Blue Cross Blue Shield, the Wellpoint Inc. unit that covers Christman through his employer, won't pay for the $500 genetic test that could tell them if the children are at risk. Bloomberg's John Lauerman reports. (Source: Bloomberg)

Barclays CEO Jes Staley Says Shareholders Still Back Him
36:41 - Jes Staley, chief executive officer at Barclays, discusses the whistleblower investigation and continued support from shareholders. He spoke exclusively on "Bloomberg Daybreak: Europe." (Source: Bloomberg)
  • Richard Haass Says Trump Policy Has Unhealthy Trinity
  • BlackRock’s Rodriguez Says Mexico a Strong Ally of U.S.
  • Hal Scott on the Rekindling of Trust in Wall Street